These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 11241696)

  • 1. Vessel size imaging.
    Troprès I; Grimault S; Vaeth A; Grillon E; Julien C; Payen JF; Lamalle L; Décorps M
    Magn Reson Med; 2001 Mar; 45(3):397-408. PubMed ID: 11241696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vessel size imaging in humans.
    Kiselev VG; Strecker R; Ziyeh S; Speck O; Hennig J
    Magn Reson Med; 2005 Mar; 53(3):553-63. PubMed ID: 15723391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MR contrast due to intravascular magnetic susceptibility perturbations.
    Boxerman JL; Hamberg LM; Rosen BR; Weisskoff RM
    Magn Reson Med; 1995 Oct; 34(4):555-66. PubMed ID: 8524024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of T(2)-weighted susceptibility contrast MRI for mapping the blood volume in the glioma-bearing rat brain.
    Le Duc G; Péoc'h M; Rémy C; Charpy O; Muller RN; Le Bas JF; Décorps M
    Magn Reson Med; 1999 Oct; 42(4):754-61. PubMed ID: 10502765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UTE-ΔR2 -ΔR2 * combined MR whole-brain angiogram using dual-contrast superparamagnetic iron oxide nanoparticles.
    Jung HS; Jin SH; Cho JH; Han SH; Lee DK; Cho H
    NMR Biomed; 2016 Jun; 29(6):690-701. PubMed ID: 27061076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor microvascular characterization using ultrasmall superparamagnetic iron oxide particles (USPIO) in an experimental breast cancer model.
    Turetschek K; Roberts TP; Floyd E; Preda A; Novikov V; Shames DM; Carter WO; Brasch RC
    J Magn Reson Imaging; 2001 Jun; 13(6):882-8. PubMed ID: 11382948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vessel size imaging using low intravascular contrast agent concentrations.
    Troprès I; Lamalle L; Farion R; Segebarth C; Rémy C
    MAGMA; 2004 Dec; 17(3-6):313-6. PubMed ID: 15580376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron-dextran as a magnetic susceptibility contrast agent: flow-related contrast effects in the T2-weighted spin-echo MRI of normal rat and cat brain.
    White DL; Aicher KP; Tzika AA; Kucharczyk J; Engelstad BL; Moseley ME
    Magn Reson Med; 1992 Mar; 24(1):14-28. PubMed ID: 1313524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MR imaging of microvasculature.
    Jensen JH; Chandra R
    Magn Reson Med; 2000 Aug; 44(2):224-30. PubMed ID: 10918321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous evaluation of vascular morphology, blood volume and transvascular permeability using SPION-based, dual-contrast MRI: imaging optimization and feasibility test.
    Kwon HJ; Shim WH; Cho G; Cho HJ; Jung HS; Lee CK; Lee YS; Baek JH; Kim EJ; Suh JY; Sung YS; Woo DC; Kim YR; Kim JK
    NMR Biomed; 2015 Jun; 28(6):624-32. PubMed ID: 25865029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo assessment of tumoral angiogenesis.
    Troprès I; Lamalle L; Péoc'h M; Farion R; Usson Y; Décorps M; Rémy C
    Magn Reson Med; 2004 Mar; 51(3):533-41. PubMed ID: 15004795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in predominant enhancement mechanisms of superparamagnetic iron oxide and ultrasmall superparamagnetic iron oxide for contrast-enhanced portal magnetic resonance angiography. Preliminary results of an animal study original investigation.
    Knollmann FD; Böck JC; Rautenberg K; Beier J; Ebert W; Felix R
    Invest Radiol; 1998 Sep; 33(9):637-43. PubMed ID: 9766048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo measurement of ADC change due to intravascular susceptibility variation.
    Does MD; Zhong J; Gore JC
    Magn Reson Med; 1999 Feb; 41(2):236-40. PubMed ID: 10080268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI of arthritis: comparison of ultrasmall superparamagnetic iron oxide vs. Gd-DTPA.
    Simon GH; von Vopelius-Feldt J; Wendland MF; Fu Y; Piontek G; Schlegel J; Chen MH; Daldrup-Link HE
    J Magn Reson Imaging; 2006 May; 23(5):720-7. PubMed ID: 16557494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High spatial resolution and high contrast visualization of brain arteries and veins: impact of blood pool contrast agent and water-selective excitation imaging at 3T.
    Spuentrup E; Jacobs JE; Kleimann JF; Wiethoff AJ; Poggenborg J; Brinker G; Loehr M; Möller-Hartmann W; Botnar RM; Ernestus RI; Lackner KJ
    Rofo; 2010 Dec; 182(12):1097-104. PubMed ID: 20803412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [MRI of arthritis with the USPIO SH U 555 C: optimization of T1 enhancement].
    Simon G; Daldrup-Link H; von Vopelius-Feldt J; Wendland M; Fu Y; Schlegel J; Rummeny E
    Rofo; 2006 Feb; 178(2):200-6. PubMed ID: 16435251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vessel size index magnetic resonance imaging to monitor the effect of antivascular treatment in a rodent tumor model.
    Howe FA; McPhail LD; Griffiths JR; McIntyre DJ; Robinson SP
    Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1470-6. PubMed ID: 18538948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The intravascular contrast agent Clariscan (NC 100150 injection) for 3D MR coronary angiography in patients with coronary artery disease.
    Klein C; Nagel E; Schnackenburg B; Bornstedt A; Schalla S; Hoffmann V; Lehning A; Fleck E
    MAGMA; 2000 Nov; 11(1-2):65-7. PubMed ID: 11186991
    [No Abstract]   [Full Text] [Related]  

  • 19. First-pass myocardial perfusion MR imaging with outer-volume suppression and the intravascular contrast agent NC100150 injection: preliminary results in eight patients.
    Bjerner T; Johansson L; Ericsson A; Wikström G; Hemmingsson A; Ahlström H
    Radiology; 2001 Dec; 221(3):822-6. PubMed ID: 11719685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantifying the blood oxygenation level dependent effect in cerebral blood volume-weighted functional MRI at 9.4T.
    Lu H; Scholl CA; Zuo Y; Stein EA; Yang Y
    Magn Reson Med; 2007 Sep; 58(3):616-21. PubMed ID: 17763339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.